Document: Barr Responses To QFR’s: CLR Digs Out The Relevant Q’s & A’s
Cannabis Law Report
JANUARY 30, 2019
To expand the number of manufacturers, the Drug Enforcement Administration (DEA) submitted a notice in the Federal Register on August 11, 2016, soliciting applications for licenses to manufacture marijuana for research purposes. The Food and Drug Administration (FDA) recently approved Epidiolex, whose main active ingredient is CBD.
63 
Let's personalize your content